Bodal Chemicals reported a massive 1,259% YoY surge in net profit to Rs 81 crore for Q2 FY27, fueled by strong pricing power across its dye and chemical segments. Total revenue climbed 77% to Rs 884 crore, while management maintained a FY27 revenue guidance of over Rs 3,000 crore. While the operational turnaround is robust, investors should monitor the company's high working capital cycle and the execution progress of its TCCA unit.
Bodal Chemicals Q2 Net Profit Soars 1,259% to Rs 81 Crore
Total Revenue for Q2 reached Rs 884 crore, while EBITDA grew by 197% to Rs 128 crore.
Reader Takeaway: Strong pricing tailwinds and operational efficiency drove earnings, but elevated working capital levels require close monitoring.
What just happened
Bodal Chemicals delivered a strong performance in Q2 FY27, reporting a massive 1,259% jump in consolidated net profit to Rs 81 crore. Revenue grew by 77% to Rs 884 crore, driven primarily by strong demand and favorable price realizations in its Dye Intermediates and Basic Chemicals segments. The EBITDA margin stood at 14.4% for the quarter.
Why this matters
The company’s performance highlights a structural shift in the industry, which management attributes to tightening environmental regulations in China. This shift has limited new capacity additions, allowing Bodal Chemicals to capture better price realizations. The company is now guiding for a full-year revenue exceeding Rs 3,000 crore.
The backstory
For H1 FY27, the company recorded a total revenue of Rs 1,599 crore and a net profit of Rs 112 crore, a significant improvement from the Rs 16 crore profit reported in H1 FY26. The Benzene Derivatives unit is showing strong momentum, currently operating at 85% capacity utilization as of October 2026.
Risks to watch
Investors should remain cautious about the company’s working capital cycle. Rapid revenue growth has led to stretched inventory and receivables, which management expects will stabilize. Additionally, the TCCA unit is currently at a break-even point; its success depends on the procurement of domestic equipment to improve capacity utilization and profitability.
What to track next
Watch for stabilization in the working capital cycle in coming quarters and the operational contribution from the Benzene Derivatives segment. The management's ability to maintain EBITDA margins amidst potential price cyclicality in the dye business will also be a key factor for sustained valuation.